You'd think that Sinclair,
Westphal and
Sirtris Pharmacueticals would be less inclined to push the media/press envelope now that
Sirtris is part of
GlaxoSmithKline. Not true. See the latest feature
article in the NY Times. One interesting excerpt: Glaxo is considering the marketing of
SRT501 as ad over the counter
resveratrol supplement. If you are looking to try resveratrol today be sure to vist SI Blog sponsors on this page.
No comments:
Post a Comment